🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/03/2009 | 29,95 | 31,17 | 29,60 | 29,85 | -9,93% | 5,26% | 4.643.200 |
| 13/03/2009 | 31,32 | 33,58 | 31,20 | 33,14 | +5,98% | 7,58% | 1.711.800 |
| 12/03/2009 | 29,66 | 31,50 | 29,37 | 31,27 | +5,66% | 7,17% | 1.318.400 |
| 11/03/2009 | 31,82 | 32,21 | 29,40 | 29,60 | -6,24% | 8,83% | 1.976.600 |
| 10/03/2009 | 32,25 | 32,84 | 31,17 | 31,57 | -0,46% | 5,18% | 1.392.400 |
| 09/03/2009 | 31,50 | 32,41 | 31,45 | 31,71 | +0,73% | 3,05% | 507.000 |
| 06/03/2009 | 31,69 | 32,13 | 31,07 | 31,48 | +0,24% | 3,33% | 758.600 |
| 05/03/2009 | 32,32 | 32,59 | 31,16 | 31,41 | -4,30% | 4,43% | 607.800 |
| 04/03/2009 | 32,09 | 33,20 | 31,75 | 32,82 | +2,85% | 4,52% | 804.600 |
| 03/03/2009 | 32,22 | 32,41 | 31,04 | 31,91 | +1,25% | 4,24% | 1.499.800 |
| 02/03/2009 | 33,44 | 33,46 | 31,35 | 31,51 | -6,09% | 6,31% | 1.415.200 |
| 27/02/2009 | 34,64 | 34,85 | 33,35 | 33,56 | -3,99% | 4,32% | 1.182.400 |
| 26/02/2009 | 36,70 | 36,90 | 34,39 | 34,95 | -4,61% | 6,84% | 1.267.800 |
| 25/02/2009 | 36,15 | 37,18 | 35,84 | 36,64 | +0,59% | 3,69% | 1.021.000 |
| 24/02/2009 | 35,81 | 36,64 | 35,35 | 36,43 | +2,61% | 3,59% | 1.037.600 |
| 23/02/2009 | 34,59 | 36,14 | 34,47 | 35,50 | +2,63% | 4,83% | 1.316.600 |
| 20/02/2009 | 34,89 | 35,10 | 34,31 | 34,59 | -1,66% | 2,26% | 1.390.600 |
| 19/02/2009 | 36,22 | 36,56 | 35,03 | 35,18 | -2,54% | 4,21% | 848.600 |
| 18/02/2009 | 36,32 | 36,50 | 35,74 | 36,09 | -0,76% | 2,08% | 1.681.600 |
| 17/02/2009 | 36,00 | 36,67 | 34,96 | 36,37 | +0,40% | 4,76% | 1.672.800 |
| 13/02/2009 | 35,72 | 36,50 | 35,49 | 36,22 | +1,16% | 2,83% | 845.800 |
| 12/02/2009 | 34,64 | 35,91 | 34,56 | 35,81 | +2,23% | 3,91% | 1.071.800 |
| 11/02/2009 | 34,80 | 35,22 | 34,57 | 35,03 | +0,16% | 1,85% | 469.200 |
| 10/02/2009 | 35,59 | 36,25 | 34,70 | 34,97 | -1,73% | 4,37% | 901.000 |
| 09/02/2009 | 35,08 | 35,64 | 34,98 | 35,59 | +0,81% | 1,88% | 681.200 |
| 06/02/2009 | 34,92 | 35,50 | 34,83 | 35,30 | +1,48% | 1,92% | 1.411.200 |
| 05/02/2009 | 33,60 | 34,99 | 33,60 | 34,79 | +3,07% | 4,14% | 1.391.400 |
| 04/02/2009 | 34,16 | 34,16 | 33,15 | 33,75 | -0,76% | 2,97% | 1.279.200 |
| 03/02/2009 | 33,42 | 34,01 | 33,14 | 34,01 | +2,06% | 2,60% | 1.298.400 |
| 02/02/2009 | 33,46 | 33,86 | 33,20 | 33,33 | -1,91% | 1,99% | 806.200 |